Cannabis Bioscience International Holdings (CBIH) FCF Margin (2023 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly FCF Margin came in at 130.27% in Q1 2026, up 42436.0% year-on-year from N/an in Q1 2025, and down 1163.26% quarter-over-quarter from 10.31% in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) FCF Margin (2023 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed FCF Margin across 4 years of filings, most recently posting 130.27% for Q1 2026.
- FCF Margin for Q1 2026 came in at 130.27%, up 42436.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 216.87% (down 11227.0% YoY), and the FY2025 annual result was 108.78%, up 8387.0% from the prior year.
- FCF Margin came in at 130.27% for Q1 2026 at Cannabis Bioscience International Holdings, down from 10.31% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 10.31% in Q4 2025 to a low of 554.63% in Q1 2025.
- The 4-year median for FCF Margin is 229.94% (2024), against an average of 242.49%.
- Across the five-year window, FCF Margin plunged 52970 bps in 2025 and soared 42436 bps in 2026, its largest moves.
- Cannabis Bioscience International Holdings' FCF Margin stood at 347.07% in 2023, then jumped by 72 bps to 97.09% in 2024, then soared by 89 bps to 10.31% in 2025, then slumped by 1163 bps to 130.27% in 2026.
- The last three FCF Margin figures came in at 130.27% (Q1 2026), 10.31% (Q4 2025), and 428.56% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -429.96% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 13.24% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 32.62% |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | -130.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -130.27% |
| Nov 30, 2025 | -10.31% |
| Aug 31, 2025 | -428.56% |
| May 31, 2025 | -412.84% |
| Feb 28, 2025 | -554.63% |
| Nov 30, 2024 | -97.09% |
| Aug 31, 2024 | -17.00% |
| May 31, 2024 | -229.94% |
| Feb 29, 2024 | -24.93% |
| Nov 30, 2023 | -347.07% |
| Aug 31, 2023 | -102.47% |
| May 31, 2023 | -404.75% |
| Feb 28, 2023 | -392.53% |